Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H2JQ
|
||||
Former ID |
DIB014312
|
||||
Drug Name |
NB-506
|
||||
Synonyms |
J-107185; L-753000; N-[12-(beta-D-Glucopyranosyl)-1,11-dihydroxy-5,7-dioxo-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-6-yl]formamide; 6-(Formamido)-12-(beta-D-glucopyranosyl)-1,11-dihydroxy-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Discontinued in Phase 2 | [545864] | ||
Structure |
Download2D MOL |
||||
CAS Number |
CAS 151069-12-4
|
||||
Target and Pathway | |||||
Target(s) | Human DNA | Target Info | Inhibitor | [526318] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.